What Is Just the Right Amount of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema?: Protocol V and the Goldilocks Principle

Michael A Grassi^{1

2}

Affiliations

¹ Grassi Retina, Naperville, Illinois.
² Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago.

Comment

Michael A Grassi. JAMA Ophthalmol. 2021.

. 2021 Apr 1;139(4):381-382.

doi: 10.1001/jamaophthalmol.2021.0013.

Michael A Grassi^{1

2}

¹ Grassi Retina, Naperville, Illinois.
² Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago.

No abstract available

Comment in

Managing Center-Involved Diabetic Macular Edema With Good Visual Acuity-Reply.
Grassi MA. Grassi MA. JAMA Ophthalmol. 2022 Jan 1;140(1):96-97. doi: 10.1001/jamaophthalmol.2021.4659. JAMA Ophthalmol. 2022. PMID: 34762096 No abstract available.
Managing Center-Involved Diabetic Macular Edema With Good Visual Acuity.
Sun JK, Glassman AR, Jampol LM. Sun JK, et al. JAMA Ophthalmol. 2022 Jan 1;140(1):95-96. doi: 10.1001/jamaophthalmol.2021.4664. JAMA Ophthalmol. 2022. PMID: 34762102 No abstract available.

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, Grover S, Jampol LM, Jhaveri CD, Melia M, Stockdale CR, Martin DF, Sun JK; DRCR Retina Network. Baker CW, et al. JAMA. 2019 May 21;321(19):1880-1894. doi: 10.1001/jama.2019.5790. JAMA. 2019. PMID: 31037289 Free PMC article. Clinical Trial.